|
1
|
Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: A multicenter study.
|
Cancer
|
2010
|
1.18
|
|
2
|
The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma.
|
PLoS One
|
2011
|
1.11
|
|
3
|
Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.
|
J Neurooncol
|
2010
|
1.05
|
|
4
|
Metastatic skull tumors: MRI features and a new conventional classification.
|
J Neurooncol
|
2010
|
1.02
|
|
5
|
Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure.
|
Lung Cancer
|
2011
|
1.02
|
|
6
|
Radiotherapy for patients with symptomatic intramedullary spinal cord metastasis.
|
J Radiat Res
|
2011
|
1.00
|
|
7
|
Immunohistochemical analysis-based proteomic subclassification of newly diagnosed glioblastomas.
|
Cancer Sci
|
2012
|
0.93
|
|
8
|
Occurrence and clinical features of brain metastasis after chemoradiotherapy for esophageal carcinoma.
|
J Radiat Res
|
2011
|
0.91
|
|
9
|
α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.
|
BMC Cancer
|
2012
|
0.91
|
|
10
|
Leptomeningeal carcinomatosis associated with gastric cancer.
|
Int J Clin Oncol
|
2011
|
0.91
|
|
11
|
Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
|
Int J Oncol
|
2013
|
0.90
|
|
12
|
Feasibility of proton beam therapy for chordoma and chondrosarcoma of the skull base.
|
Skull Base
|
2011
|
0.87
|
|
13
|
Growth curve analysis of asymptomatic and symptomatic meningiomas.
|
J Neurooncol
|
2010
|
0.87
|
|
14
|
O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.
|
Brain Tumor Pathol
|
2011
|
0.86
|
|
15
|
Pleomorphic xanthoastrocytoma and moyamoya disease in a patient with neurofibromatosis type 1 - case report - .
|
Neurol Med Chir (Tokyo)
|
2011
|
0.80
|
|
16
|
Ectopic growth hormone-releasing adenoma in the cavernous sinus--case report.
|
Neurol Med Chir (Tokyo)
|
2004
|
0.78
|
|
17
|
[Cotton-Dam Wash Cytology:A Technique for Diagnosis and Prevention of Dissemination during Resection of Metastatic Brain Tumors].
|
No Shinkei Geka
|
2017
|
0.75
|
|
18
|
[Metastatic brain tumors from gastrointestinal cancer: an analysis of patient background and treatment results].
|
No Shinkei Geka
|
2013
|
0.75
|
|
19
|
Metastatic brain tumors from small-cell esophageal cancer: clinical characteristics and outcome.
|
J Cancer Res Ther
|
2014
|
0.75
|
|
20
|
[Leptomeningeal Dissemination in Patients with Pituitary Metastasis from Breast Cancer].
|
No Shinkei Geka
|
2016
|
0.75
|
|
21
|
[Posterior Reversible Encephalopathy Syndrome Associated with Cancer Therapy].
|
No Shinkei Geka
|
2016
|
0.75
|
|
22
|
Immunohistochemical proliferation markers may overestimate the growth potential after ionizing radiation: in vivo study in the rat anterior pituitary gland.
|
Neurol Med Chir (Tokyo)
|
2003
|
0.75
|
|
23
|
Detection of tumor progression by signal intensity increase on fluid-attenuated inversion recovery magnetic resonance images in the resection cavity of high-grade gliomas.
|
Neurol Med Chir (Tokyo)
|
2013
|
0.75
|
|
24
|
Melanocytic medulloblastoma with ganglioneurocytomatous differentiation: a case report.
|
Neuropathology
|
2008
|
0.75
|
|
25
|
Tissue plasminogen activator levels after single intracisternal injection in patients with subarachnoid hemorrhage.
|
Neurol Med Chir (Tokyo)
|
2004
|
0.75
|
|
26
|
[Working lives of women neurosurgeons (discussion)].
|
No Shinkei Geka
|
2008
|
0.75
|
|
27
|
[Multidisciplinary treatment of leptomeningeal metastasis in patients with lung adenocarcinoma: the triple modality combination of EGFR-TKI, VP shunt and irradiation].
|
No Shinkei Geka
|
2012
|
0.75
|
|
28
|
Prognostic factors in patients with brain metastasis from non-small cell lung cancer treated with whole-brain radiotherapy.
|
J Cancer Res Ther
|
2016
|
0.75
|